CR2 Gene Immunodeficiency Common Variable Type 7 Genetic Test
Introduction
CR2 gene immunodeficiency, also known as common variable immunodeficiency type 7 (CVID7), is a rare genetic disorder that affects the immune system. This blog post will provide detailed information about the CR2 Gene Immunodeficiency Common Variable Type 7 Genetic Test offered at DNA Labs UAE.
Test Name: CR2 Gene Immunodeficiency Common Variable Type 7 Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for CR2 Gene Immunodeficiency, common variable type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CR2 Gene Immunodeficiency, common variable type 7 NGS Genetic DNA Test gene CR2.
Test Details
CR2 gene immunodeficiency, also known as common variable immunodeficiency type 7 (CVID7), is a rare genetic disorder that affects the immune system. It is caused by mutations in the CR2 gene, which provides instructions for making a protein called complement receptor 2. The complement system is a part of the immune system that helps to eliminate foreign substances such as bacteria and viruses. Complement receptor 2 plays a crucial role in the activation of the complement system.
Mutations in the CR2 gene can lead to a deficiency or dysfunction of complement receptor 2, resulting in a weakened immune response. This can make individuals more susceptible to recurrent infections, particularly respiratory tract infections, and can also lead to other complications such as autoimmune disorders, gastrointestinal issues, and lymphoproliferative disorders.
NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations in the CR2 gene. It involves analyzing the individual’s DNA to detect any variations or abnormalities in the gene sequence. This test can help confirm a diagnosis of CR2 gene immunodeficiency/CVID7 and provide information about the specific mutation(s) present.
Genetic testing can be helpful for individuals with suspected immunodeficiency disorders, as it can aid in proper diagnosis, inform treatment decisions, and provide information about the risk of passing the condition to future generations. It can also help in genetic counseling and family planning.
It’s important to note that CR2 gene immunodeficiency/CVID7 is a rare condition, and genetic testing for this specific disorder may not be widely available. A healthcare professional or genetic counselor can provide more information about the availability and appropriateness of genetic testing for CR2 gene immunodeficiency/CVID7 in individual cases.
| Test Name | CR2 Gene Immunodeficiency common variable type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CR2 Gene Immunodeficiency, common variable type 7 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CR2 Gene Immunodeficiency, common variable type 7 NGS Genetic DNA Test gene CR2 |
| Test Details |
CR2 gene immunodeficiency, also known as common variable immunodeficiency type 7 (CVID7), is a rare genetic disorder that affects the immune system. It is caused by mutations in the CR2 gene, which provides instructions for making a protein called complement receptor 2. The complement system is a part of the immune system that helps to eliminate foreign substances such as bacteria and viruses. Complement receptor 2 plays a crucial role in the activation of the complement system. Mutations in the CR2 gene can lead to a deficiency or dysfunction of complement receptor 2, resulting in a weakened immune response. This can make individuals more susceptible to recurrent infections, particularly respiratory tract infections, and can also lead to other complications such as autoimmune disorders, gastrointestinal issues, and lymphoproliferative disorders. NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations in the CR2 gene. It involves analyzing the individual’s DNA to detect any variations or abnormalities in the gene sequence. This test can help confirm a diagnosis of CR2 gene immunodeficiency/CVID7 and provide information about the specific mutation(s) present. Genetic testing can be helpful for individuals with suspected immunodeficiency disorders, as it can aid in proper diagnosis, inform treatment decisions, and provide information about the risk of passing the condition to future generations. It can also help in genetic counseling and family planning. It’s important to note that CR2 gene immunodeficiency/CVID7 is a rare condition, and genetic testing for this specific disorder may not be widely available. A healthcare professional or genetic counselor can provide more information about the availability and appropriateness of genetic testing for CR2 gene immunodeficiency/CVID7 in individual cases. |
